NO883447L - Stabilisert antracyklinpreparat. - Google Patents

Stabilisert antracyklinpreparat.

Info

Publication number
NO883447L
NO883447L NO88883447A NO883447A NO883447L NO 883447 L NO883447 L NO 883447L NO 88883447 A NO88883447 A NO 88883447A NO 883447 A NO883447 A NO 883447A NO 883447 L NO883447 L NO 883447L
Authority
NO
Norway
Prior art keywords
stabilized
preparation
antracycline
salts
pentopyranosyl
Prior art date
Application number
NO88883447A
Other languages
English (en)
Other versions
NO175134B (no
NO175134C (no
NO883447D0 (no
Inventor
Yasuhisa Sakamaki
Yukio Ozaki
Norihiko Tanno
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of NO883447D0 publication Critical patent/NO883447D0/no
Publication of NO883447L publication Critical patent/NO883447L/no
Publication of NO175134B publication Critical patent/NO175134B/no
Publication of NO175134C publication Critical patent/NO175134C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO883447A 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav NO175134C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62197032A JP2603480B2 (ja) 1987-08-05 1987-08-05 安定化されたアンスラサイクリン系製剤

Publications (4)

Publication Number Publication Date
NO883447D0 NO883447D0 (no) 1988-08-03
NO883447L true NO883447L (no) 1989-02-06
NO175134B NO175134B (no) 1994-05-30
NO175134C NO175134C (no) 1994-09-07

Family

ID=16367605

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883447A NO175134C (no) 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav

Country Status (14)

Country Link
US (1) US4952566A (no)
EP (1) EP0302729B1 (no)
JP (1) JP2603480B2 (no)
KR (1) KR970000507B1 (no)
AT (1) ATE71526T1 (no)
AU (1) AU609168B2 (no)
CA (1) CA1324959C (no)
DE (1) DE3867751D1 (no)
DK (1) DK173317B1 (no)
ES (1) ES2038763T3 (no)
FI (1) FI91483C (no)
GR (1) GR3004330T3 (no)
NO (1) NO175134C (no)
NZ (1) NZ225654A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
FR2665834B1 (fr) * 1991-07-24 2001-02-23 Sandoz Sa Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
WO1999028331A2 (en) * 1997-11-28 1999-06-10 Sumitomo Pharmaceuticals Co., Ltd. Crystalline amrubicin hydrochloride
WO2003035660A1 (en) * 2001-10-23 2003-05-01 Sumitomo Chemical Company, Limited Stabilization of amrubicin hydrochloride
JP4594736B2 (ja) * 2002-11-29 2010-12-08 大日本住友製薬株式会社 安定化されたアンスラサイクリン系化合物の凍結乾燥製剤
CN100395255C (zh) * 2005-02-02 2008-06-18 江苏豪森药业股份有限公司 马来酸氨柔比星盐及其制备方法和用途
KR20070088447A (ko) * 2005-05-11 2007-08-29 시코르, 인크. 안정한 동결건조된 안트라사이클린 글리코시드
DK2436386T3 (en) 2009-05-27 2014-12-15 Sumitomo Dainippon Pharma Co Ltd A stabilized and lyophilized formulation of the anthracycline compounds
BR112015014478A2 (pt) * 2012-12-19 2017-07-11 Colgate Palmolive Co complexo de haleto de aminoácido e zinco com cisteína
WO2016024369A1 (ja) * 2014-08-13 2016-02-18 テバ製薬株式会社 がん治療用医薬組成物
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
US4540695A (en) * 1981-08-12 1985-09-10 Sumitomo Chemical Co., Ltd. Aminonaphthacene derivatives and their use
JPS5976099A (ja) * 1982-10-22 1984-04-28 Sumitomo Chem Co Ltd アミノナフタセン誘導体とその製造方法
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
NO175134B (no) 1994-05-30
KR970000507B1 (ko) 1997-01-13
KR890003791A (ko) 1989-04-18
EP0302729B1 (en) 1992-01-15
AU609168B2 (en) 1991-04-26
FI91483B (fi) 1994-03-31
JP2603480B2 (ja) 1997-04-23
ES2038763T3 (es) 1993-08-01
NO175134C (no) 1994-09-07
FI883602L (fi) 1989-02-06
AU2042188A (en) 1989-02-09
FI883602A0 (fi) 1988-08-01
DK436688D0 (da) 1988-08-04
DK173317B1 (da) 2000-07-17
CA1324959C (en) 1993-12-07
DK436688A (da) 1989-02-06
FI91483C (fi) 1994-07-11
ATE71526T1 (de) 1992-02-15
NO883447D0 (no) 1988-08-03
DE3867751D1 (de) 1992-02-27
US4952566A (en) 1990-08-28
NZ225654A (en) 1991-03-26
JPS6440493A (en) 1989-02-10
GR3004330T3 (no) 1993-03-31
EP0302729A1 (en) 1989-02-08

Similar Documents

Publication Publication Date Title
NO883447L (no) Stabilisert antracyklinpreparat.
FR2629819B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
NO941726D0 (no) Fremgangsmåte for fremstilling av 4-amino-1-hydroxy-butyliden-1,2-bisfosfonsyre
FR2629818B1 (fr) Procede de preparation du taxol
PT88448A (pt) Process for preparing antiprotozoal pharmaceutical compositionscontaining azithromycin or a derivative thereof
DE68925963D1 (de) Chemilimineszente 1,2-Dioxetan-Verbindungen
PT92016A (pt) Processo de preparacao de 3-furaldeidos substituidos na posicao 5
SE7606808L (sv) Forfarande for framstellning av antracykliner och optiskt aktiva antracyklinoner
DK0430645T3 (da) Vacciner
DE3874352D1 (de) Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
DE3685764D1 (de) Antibiotikum hergestellt von lysobacter sp. sc 14,067.
DK0443471T3 (da) 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater
FI903030A0 (fi) Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
SE7709234L (sv) Antitumorantibiotika
FI892949L (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen -pg12-derivat, foerfarande foer dess framstaellning och dess anvaendning.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
ATE87926T1 (de) Ethylierte avermectine.
DE69004151D1 (de) FR115224 enthaltende Zusammensetzung für eine parenterale Verabreichung.
ATE97908T1 (de) Platin-(ii)-diamin-komplex, verfahren zur herstellung dieser verbindung, zusammensetzung mit antitumorwirkung, die mindestens eine platin- verbindung enthaelt, und geformte zusammensetzung mit antitumorwirkung.
DK214087A (da) Compleximmunogen
MX168553B (es) Procedimiento para la preparacion de bis(etoxi-tiocarbonil)sulfuro
GR3006580T3 (no)
DK587585A (da) 13 alfa-alkyl-17 beta-(3-acyloxypropyl)-gonaner, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse forbindelser
ES2053697T3 (es) Dactilociclina a y dactilociclina b.
OA08918A (fr) Procédé d'enrichissement de la canallite par flottation.

Legal Events

Date Code Title Description
MK1K Patent expired